Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Children With CNS Rhabdoid Tumor
NCT00003469Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Feb 1996
- Primary completion
- May 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in atypical teratoid/rhabdoid tumor of the central nervous system (AT/RT), sponsored by Burzynski Research Institute. Started Feb 1996; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
atypical teratoid/rhabdoid tumor of the central nervous system (AT/RT)
Beyond the preview
Go deeper on NCT00003469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003469.